GlaxoSmithKline's experience of incurred sample reanalysis for dried blood spot samples
| Autor: | Matthew Barfield, Maria Busz, Subutai Ahmad |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Quality Control
Blood Specimen Collection Clinical Biochemistry Reproducibility of Results Sample (statistics) Guidelines as Topic General Medicine Validation Studies as Topic Mass Spectrometry Analytical Chemistry Cost savings Dried blood spot Medical Laboratory Technology Statistics Environmental science Humans General Pharmacology Toxicology and Pharmaceutics Dried blood Artifacts Blood Chemical Analysis Chromatography Liquid Reagent Strips |
| Zdroj: | Bioanalysis. 3(9) |
| ISSN: | 1757-6199 |
| Popis: | Dried blood spots are becoming a popular alternative to plasma for many different applications. This has been driven by animal ethics but also by ease of use and cost savings. Recent regulatory guidance now has a requirement for incurred sample reanalysis. This article details three examples of incurred sample reanalysis using dried blood spot samples. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|